| |  Online-Ressource |
|---|
| Verfasst von: | Rajakumar, Timothy [VerfasserIn]  |
|---|
| | Horos, Rastislav [VerfasserIn] |
|---|
| | Jehn, Julia [VerfasserIn] |
|---|
| | Schenz, Judith [VerfasserIn] |
|---|
| | Muley, Thomas [VerfasserIn] |
|---|
| | Pelea, Oana [VerfasserIn] |
|---|
| | Hofmann, Sarah [VerfasserIn] |
|---|
| | Kittner, Paul [VerfasserIn] |
|---|
| | Kahraman, Mustafa [VerfasserIn] |
|---|
| | Heuvelman, Marco [VerfasserIn] |
|---|
| | Sikosek, Tobias [VerfasserIn] |
|---|
| | Feufel, Jennifer [VerfasserIn] |
|---|
| | Skottke, Jasmin [VerfasserIn] |
|---|
| | Nötzel, Dennis [VerfasserIn] |
|---|
| | Hinkfoth, Franziska [VerfasserIn] |
|---|
| | Tikk, Kaja [VerfasserIn] |
|---|
| | Daniel-Moreno, Alberto [VerfasserIn] |
|---|
| | Ceiler, Jessika [VerfasserIn] |
|---|
| | Mercaldo, Nathaniel [VerfasserIn] |
|---|
| | Uhle, Florian [VerfasserIn] |
|---|
| | Uhle, Sandra [VerfasserIn] |
|---|
| | Weigand, Markus A. [VerfasserIn] |
|---|
| | Elshiaty, Mariam [VerfasserIn] |
|---|
| | Lusky, Fabienne [VerfasserIn] |
|---|
| | Schindler, Hannah [VerfasserIn] |
|---|
| | Ferry, Quentin [VerfasserIn] |
|---|
| | Sauka-Spengler, Tatjana [VerfasserIn] |
|---|
| | Wu, Qianxin [VerfasserIn] |
|---|
| | Rabe, Klaus F. [VerfasserIn] |
|---|
| | Reck, Martin [VerfasserIn] |
|---|
| | Thomas, Michael [VerfasserIn] |
|---|
| | Christopoulos, Petros [VerfasserIn] |
|---|
| | Steinkraus, Bruno R. [VerfasserIn] |
|---|
| Titel: | A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy |
|---|
| Verf.angabe: | Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofmann, Paul Kittner, Mustafa Kahraman, Marco Heuvelman, Tobias Sikosek, Jennifer Feufel, Jasmin Skottke, Dennis Nötzel, Franziska Hinkfoth, Kaja Tikk, Alberto Daniel-Moreno, Jessika Ceiler, Nathaniel Mercaldo, Florian Uhle, Sandra Uhle, Markus A. Weigand, Mariam Elshiaty, Fabienne Lusky, Hannah Schindler, Quentin Ferry, Tatjana Sauka-Spengler, Qianxin Wu, Klaus F. Rabe, Martin Reck, Michael Thomas, Petros Christopoulos, Bruno R. Steinkraus |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 31 March 2022 |
|---|
| Umfang: | 13 S. |
|---|
| Fussnoten: | Published: 31 March 2022 ; Gesehen am 29.09.2022 |
|---|
| Titel Quelle: | Enthalten in: npj precision oncology |
|---|
| Ort Quelle: | [London] : Springer Nature, 2017 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 6(2022), Artikel-ID 19, Seite 1-13 |
|---|
| ISSN Quelle: | 2397-768X |
|---|
| Abstract: | Immunotherapies have recently gained traction as highly effective therapies in a subset of late-stage cancers. Unfortunately, only a minority of patients experience the remarkable benefits of immunotherapies, whilst others fail to respond or even come to harm through immune-related adverse events. For immunotherapies within the PD-1/PD-L1 inhibitor class, patient stratification is currently performed using tumor (tissue-based) PD-L1 expression. However, PD-L1 is an accurate predictor of response in only ~30% of cases. There is pressing need for more accurate biomarkers for immunotherapy response prediction. We sought to identify peripheral blood biomarkers, predictive of response to immunotherapies against lung cancer, based on whole blood microRNA profiling. Using three well-characterized cohorts consisting of a total of 334 stage IV NSCLC patients, we have defined a 5 microRNA risk score (miRisk) that is predictive of overall survival following immunotherapy in training and independent validation (HR 2.40, 95% CI 1.37-4.19; P < 0.01) cohorts. We have traced the signature to a myeloid origin and performed miRNA target prediction to make a direct mechanistic link to the PD-L1 signaling pathway and PD-L1 itself. The miRisk score offers a potential blood-based companion diagnostic for immunotherapy that outperforms tissue-based PD-L1 staining. |
|---|
| DOI: | doi:10.1038/s41698-022-00262-y |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1038/s41698-022-00262-y |
|---|
| | Volltext: https://www.nature.com/articles/s41698-022-00262-y |
|---|
| | DOI: https://doi.org/10.1038/s41698-022-00262-y |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Cancer immunotherapy |
|---|
| | Non-coding RNAs |
|---|
| | Non-small-cell lung cancer |
|---|
| K10plus-PPN: | 181782841X |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
¬A¬ blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy / Rajakumar, Timothy [VerfasserIn]; 31 March 2022 (Online-Ressource)
